Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
Epinephrine
(Primitine, Bronkaid) HCl (Adrenaline) & Borate(Epinol) |
-Potent vasopressor
-a&b direct acting agonist -Tx of bronchospasms, hypersensitivity, prolongs anesthetics, restores heart rhythm |
|
Norepinephrine Bitartrate
(Levophed) |
-a&b direct acting agonist
-Used in tx of shock -Potent a agonist w/ little action on B2 receptors |
|
Polyhydroxyphenyl Compounds
|
-Readily undergo 2 oxidations; 1st to semiquinone(pink); 2nd to quinone(brown)
|
|
Dipivefrin Hcl
(Propine) |
-a&b direct acting agonist
-Diester of epinephrine and pivalic acid -Prodrug -Pivalic acid esters increase lipophilicity and better penetration of eye -Tx of glaucoma |
|
Dobutamine HCl
(Dobutrex) |
-Dopamine w/ aromatic substituent but acts at alpha and beta receptors
-Used for cardiac stimulation |
|
Phenylephrine HCl
(Neosynephrine) |
-alpha direct acting agonist
-only has 1 OH group off ring; not at 4-position -a-agonist activity -Used as nasal decongestant and mydriatic |
|
Metaraminol Bitartrate
(Aramine) |
-a-direct acting agonist
-only has 1 OH group off ring; not at 4-position -Used as hypotension agent |
|
Methoxamine HCl
(Vasoxyl) |
-a-direct acting agonist
-2,5 methoxy groups -Used as hypotension agent |
|
Midodrine HCl
(Proamatine) |
-a-direct acting agonist
-a1-agonist prodrug used for tx off hypotension |
|
Imidazolines
|
-a-direct acting agent
-5 membered ring, 2 N's, 1 double bond -Interact selectively at a-1 |
|
Xylometazoline (Otrivin)
Oxymetazoline HCl (Afrin) Naphazoline HCl (Prinvine) Tetrahydrozoline HCl (Visine) |
-Imidazolines
-a-direct acting agonists -OTC nasal and ocular decongestants |
|
Clonidine (Catapres)
|
-Guanidine containing imidazoline compound
-Selective for a-2 agonists -Tx of hypertension |
|
Guanabenz Acetate (Wytensin)
Guanfacine HCl (Tenex) |
-Acyclic form of clonidine
-a-2 agonist -Tx of hypertension |
|
Tizanidine HCl (Zanaflex)
|
-Guanidine containing compound with aminoimidazoline activity like clonidine
-a-2 agonist used in Tx of muscle spasticity |
|
Apraclonidine HCl (Iodipine)
|
-a-2 agonist
-More ionized than clonidine because of presence of para amino group -Tx to reduce intraocular pressure |
|
Brimonidine (Alphagan)
|
-selective for a-2 receptors
-Ophthalmic solution applied topically but can have systemic side effects |
|
Isoproterenol HCl (Isuprel)
Isoproterenol Sulfate (Medihaler-Iso |
-Potent B1 and B2 agonist activity
-Large substituent on N --> B2 -Absorbed parenterally or aerosol |
|
Bitolerol Mesylate (Tornalate) -->
Colterol |
-Biltolerol is prodrug of colterol
-B2 agonist -Ester groups on Bitolerol protect it from COMT |
|
a-Ethylnorepinephrine (Bronkephrin)
|
-B1 and B2 agonist
-A agonist activity is decreased because has ethyl instead of methyl at alpha position next to amine -Bronchodilator |
|
Isoetharine HCl (Arm-a-med)
|
-Increased steric bulk
-More B2 activity -Bronchodilator |
|
Albuterol (Proventil)
Albuterol Sulfate (Ventolin) |
-High B2 selectivity
-3-position -CH3OH group on aromatic ring and t-butyl on N -Bronchodilator |
|
Levalbuterol (Xopenex)
|
-Isolated R-isomer of albuterol
-Therapeutically active agent -B2 selectivity -Bronchodilator |
|
Pirbuterol Acetate (Maxair)
|
-Similar to albuterol
-Contains Pyridine ring instead of benzene ring -Metabolized by sulfate conjugation |
|
Salmeterol Xinafoate (Serevent)
|
-Highly B2 selective
-Large N substituent with ether and benzene group -Lipophilic --> enhances penetration of bronchial tissues -Ether allows O binding outside of receptor site and prolonged duration of action -Slow onset of action --> used long term -Tx of bronchospasms |
|
Formoterol Fumerate (Foradil)
|
-Long acting B2 agonist
-Used in asthma, COPD -Especially useful in nocturnal asthma |
|
Ritoridine HCl (Yutopar)
|
-Required solo -OH group in 4-position on benzene ring
-Large substituent on Amine -B2 selectivity -Inhibits uterine contractions in preterm labor |
|
Ephedrine
|
-Mixed/Indirect acting agent
-No catechol groups (COMT can't break it down) -Polarity decreased -BBB penetration increased -a-position CH3 group which inhibits MAO metabolism which increases intraneuronal release of catecholamines |
|
Amphetamine
|
-D-isomer more active in CNS
-L-isomer more active in periphery |
|
Dextroamphetamine Sulfate (Dexedrine)
|
-D-isomer of amphetamine
-Used in Tx of obesity and narcolepsy |
|
Methamphetamine HCl (Desoxyn)
|
-Same structure as amphetamine but addition of CH3 on amine
-Makes it more lipophilic; penetrates CNS |
|
Genetic Etiologies of Parkinsons
|
1)a-synuclein
2)Parkin 3)UCHL-1 |
|
MPTP and MPP
|
-Designer Drug
-MPTP is metabolized to toxic metabolite MPP+ |
|
Benztropine Mesylate (Cogentin)
Trihexyphenidyl HCl (Artane) Diphenhydramine (Benadryl) |
-Anticholinergics
-Tertiary amino ethers and alcohols with hydroxyl group on a-carbon -In free base equilibrium so can penetrate CNS |
|
Dopaminergic Therapy
|
1)Increase DA biosynthesis in brain
2)DA receptor agonists 3)Increase DA release into synaptic cleft 4)Decrease dopamine reuptake so stays in synapse longer 5)Decrease DA metabolism |
|
Levodopa
|
-Precursor of Dopamine
-Crosses BBB via amino acid transporter -Metabolized into DA when in CNS |
|
Carbidopa (Sinemet)
|
-Hydrazine analog of Levodopa
-Binds to pryidoxine binding site of dopa decarboxylase and inhibits it -Marketed in combo with levodopa |
|
Ergot Alkaloids
|
-Has agonist and antagonist actions at: tryptaminergic (serotonergic), dopaminergic, and a-adrenergic receptors
|
|
Bromocriptine Mesylate (Parlodel)
|
-Full D2 agonist
-Partial D1 agonist -Similar in structure to apomorphine |
|
Apomorphine (Apokyn)
|
-Dopaminergic agonist
-Neuroprotective -Used in poisonings and overdose -Can rescue patient from Parkinsons frozen state |
|
Cabergoline (Dostinex)
|
-Ergot Alkaloid derivative
-Long acting D2 agonist -Used to decrease prolactin levels |
|
Pramipexol Dihydrochloride (Mirapex)
|
-Non-ergot alkaloid
-D2 agonist -More potent at D3 receptor -S-enantiomer more active -Decreases L-dopa dose by 30% |
|
Ropinirole HCL (Requip)
|
-Non-ergot alkaloid
-D2 agonist -More potent at D3 receptor -Extensively metabolized by P1A2 -Used to treat restless leg syndrome |
|
Rotigotine (Neupro)
|
-Transdermal dopaminergic agonist for Parkinsons
-Higher affinity for D1 receptor -Thiophene ring that increases lipophilicity which increases transdermal ability |
|
Amantadine HCl (Symmetrel)
|
-Increases Dopamine release
|
|
Selegiline HCl (Eldepryl)
|
-Inhibits reuptake of dopamine in CNS
-Selective and irreversible inhibitor of MAO-B -Propargyl group (alkyne) - |
|
Rasagiline (Azilect)
|
-MAO-B inhibitor
-Irreversible to propargyl group also -Inhibits metabolism of dopamine -Neuroprotective and antiapoptotic -Slows neuronal deterioration in Parkinsons -Not metabolized to amphetamine |
|
Tolcapone (Tasmar)
|
-COMT Inhibitor
-Selective inhibitor of peripheral COMT -Can cause serious liver disease |
|
Entacapone (Comtan)
|
-Nitrocathecol COMT inhibitor
-Selective inhibitor of peripheral COMT |
|
B-Haloethylamines
|
-a-adrenergic antagonists
-Phenoxybenzamine HCl (Dibenzyline) -Used in pheochromacytoma -Form aziridine ring (NOT happy) -Forms covalent bond to a-receptor |
|
Imidazoline Antagonists
|
-a-adrenergic antagonists
-No substitution ortho to bridge makes them antagonists -Phentolamine and Priscoline -Used to treat hypertension |
|
Piperazinyl Quinazolines
|
-a-Adrenergic antagonists
-Used in Tx of hypertension and benign prostatic hypertrophy |
|
Prazosin HCl (Minipress)
|
-a-adrenergic antagonist
-Piperazinyl Quinazoline -Selective a-1 antagonist -Used in hypertension and prostate hypertrophy |
|
Terazosin HCl (Hytrin)
|
-a-adrenergic antagonist
-Piperazinyl Quinazoline -Contains reduced furan group -Higher specificity for a1-receptors -Longer duration of action |
|
Doxazosin Mesylate (Cardura)
|
-a-adrenergic antagonist
-Piperazinyl Quinazoline -Highly selective a1-antagonist -2 oxygens in furan |
|
Alfuzosin HCl (Uroxatral)
|
-a-adrenergic antagonist
-Piperazinyl Quinazoline -a1-antagonist -Acyclic |
|
Tamulosin HCl (Flomax)
|
-Non-Piperazinyl Quinazoline
-a1-antagonist for benign prostate hypertrophy -More potent in a1a receptors in nonvascular tissue; dont use to tx hypertension |
|
Indole Derivatives
|
-Yohimbine
-a2 and serotonergic antagonist -Tx of impotence and postural hypotension |
|
Propranolol HCl (Inderal)
|
-Non-selective B-blocker antagonist
-Highly lipophilic -High CNS penetration |
|
Nadolol (Corgard)
|
-Non-selective B-blocker antagonist
-More polar than propranolol -Decreased oral absorption -Decreased CNS penetration -Decreased hepatic uptake -Longer halflife |
|
Timolol Maleate Opthalmic Solution
|
-Non-selective B-blocker antagonist
-Lipophilic -Used for glaucoma |
|
Pindolol (Visken)
|
-B-blocker
-Intrinsic activity -Indole group -Crosses BBB |
|
Labetalol (Normodyne)
|
-Non-selective B blocker
-Differs in SARs -Antihypertensive agent |
|
Metoprolol Tartrate (Lopressor)
|
-B1 Selective antagonist
-Antihypertensive agent |
|
Atenolol (Tenormin)
|
-B-antagonist
-Amide in para postion -Hydrophilic -Little CNS penetration |
|
Esmolol HCl (Brevibloc)
|
-B1-blocker
-Used in atrial flutter, atrial fibrilation and sinus tachycardia |
|
Acebutolol HCl (Sectral)
|
-Prodrug
-Converted to Diacetolol -B1 selective antagonist |
|
Carvedilol (Coreg)
|
-b-blocker
-has vasodilator activity |
|
Carteolol and Penbutolol Sulfate
|
-Non-selective b-antagonists
|
|
Levobunolol HCl (Betagan)
|
-Nonselective B-blocker involved in tx of glaucoma
|
|
Betazolol HCl (Betopic)
|
B1 selective antagonist
-antihypertensive and tx of glaucoma |
|
Bisprolol Fumarate (Zebeta)
|
-Highly selective B1 antagonist
-2 oxygens in para position -Antihypertensive agent |
|
Sotalol (Betapace)
|
-B-antagonist
-Has sulfonamine in para postion -No ether linkage -Tx of ventricular arrythmias |
|
Propafenone HCl (Rythmol)
|
-B blocker
-Blocks sodium channels -Local anesthetic -Antiarrythmic agent |
|
Nebivolol (Bystolic)
|
-Selective for B1 receptors
-Symmetrical around N |
|
MAO-A
|
-In peripheral neurons and CNS
-Metabolizes phenolic rings -NE, Epi, DA, SE |
|
MAO-B
|
-In blood platelets and CNS
-Metabolizes nonphenolic rings and B-phenethylamines -Xenobiotics |